Identification and characterization of a putative new psychoactive substance, 2-(2-(4-chlorophenyl)acetamido)- 3-methylbutanamide, in Spain
Impacte
Scholar |
Altres documents de l'autoria: Fabregat-Safont, David; Fornís, I.; Ventura, Mireia; Gil, C.; Calzada, N.; Sancho, Juan V; Hernandez, Felix; Ibáñez, Maria
Metadades
Mostra el registre complet de l'elementcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/33596
comunitat-uji-handle3:10234/33597
comunitat-uji-handle4:
INVESTIGACIONAquest recurs és restringit
http://dx.doi.org/10.1002/dta.2182 |
Metadades
Títol
Identification and characterization of a putative new psychoactive substance, 2-(2-(4-chlorophenyl)acetamido)- 3-methylbutanamide, in SpainAutoria
Data de publicació
2017-02-28Editor
WileyCita bibliogràfica
FABREGAT-SAFONT, David; FORNÍS, I.; VENTURA, M.; GIL, C.; CALZADA, N.; SANCHO LLOPIS, Juan Vicente; HERNÁNDEZ HERNÁNDEZ, Félix; IBÁÑEZ MARTÍNEZ, María. Identification and characterization of a putative new psychoactive substance, 2-(2-(4-chlorophenyl)acetamido)- 3-methylbutanamide, in Spain. Drug Testing and Analysis (2017), v. 9, issue 7, p. 1073-1080Tipus de document
info:eu-repo/semantics/articleVersió de l'editorial
http://onlinelibrary.wiley.com/doi/10.1002/dta.2182/epdfVersió
info:eu-repo/semantics/publishedVersionParaules clau / Matèries
Resum
The term ‘new psychoactive substances’ (NPS) refers to
synthetically changed natural compounds or newly designed
compounds intended to elicit a psychotropic response such as
stimulation, hallucination or sedation ... [+]
The term ‘new psychoactive substances’ (NPS) refers to
synthetically changed natural compounds or newly designed
compounds intended to elicit a psychotropic response such as
stimulation, hallucination or sedation.
According to the European
Monitoring Centre for Drugs and Drug Addiction of the European
Union, more than 560 NPS are currently being monitored, and 98
of these substance were reported for the first time in 2015.
Despite that, there are still many NPS that are not being monitored,
and therefore their health effects are not yet studied. Hence, many
cases of intoxication and death related to NPS have been reported
in the past few years, highlighting the public health risks of these
substances.
One of the challenges of monitoring NPS is the
continuous structural evolution to evade regulation, so when one
substance is banned or controlled, several new compounds replace
it in the market. [-]
Títol del projecte o subvenció
Drug tresting and analysis (2017), v. 9, issue 7
Proyecto de investigación
1) Financial support from Generalitat Valenciana (Group of Excellence Prometeo II 2014/023); 2) Ministerio de Economía y Competitividad in Spain (project CTQ2015-65603-P); 3) The authors also acknowledge NPS-Euronet (HOME/2014/JDRUG/AG/DRUG/7086), co-funded by the European Commission; 4) Ministerio de Educación, Cultura y Deporte in Spain for his predoctoral grant (grant FPU15/2033)Drets d'accés
http://rightsstatements.org/vocab/CNE/1.0/
info:eu-repo/semantics/restrictedAccess
info:eu-repo/semantics/restrictedAccess
Apareix a les col.leccions
- IUPA_Articles [306]